Stryker SYK
NYSE SYK
$338.70 -1.28 (-0.38%)
At close: Aug 20, 2026 · 11:15 AM UTC

Stryker (SYK) Long-Term Investments (2009 - 2010)

Stryker (SYK) posted quarterly Long-Term Investments of -$110.0 million for Q4 2010, down 170.06% year-over-year from $157.0 million in Q4 2009, and down 170.06% on a QoQ basis from $157.0 million in Q4 2009.

Stryker (SYK) Long-Term Investments (2009 - 2010) Analysis & Trends

Stryker has reported Long-Term Investments for 2 years, with the latest figure at -$110.0 million in Q4 2010.

  • Long-Term Investments for Q4 2010 came in at -$110.0 million, down 170.06% year-over-year; the trailing twelve-month figure through Dec 2010 was -$110.0 million (down 170.06% YoY), and the FY2010 annual result was -$110.0 million, down 170.06% from the prior year.
  • Long-Term Investments slipped to -$110.0 million in Q4 2010, from $157.0 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $157.0 million in Q4 2009 and troughed at -$110.0 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 1.11 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn -
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn -
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 2.25 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 244.10 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn -
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn 175.52 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn -
10 Zimmer Biomet Holdings 19.36 Bn 18.95 Bn 1.54 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2010 -110.00 Mn
Dec 31, 2009 157.00 Mn